Lycera
Biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€109—163m (Dealroom.co estimates Jun 2015.)
Ann Arbor Michigan (HQ)
Authorizing premium user...